Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-0.26x - -0.04x - - - - 9.59M
28.36x5.53x0.62x7.48x22.28x23.46x0.05% 50.17B
16.9x3.12x-1.43x5.07x11.51x13.36x1.75% 43.62B
-54.72x63.28x0.91x17.39x-58.82x-59.75x-.--% 30.43B
-20.9x1.26x6.27x5.55x-10.88x-8.44x-.--% 28.22B
-21.2x101.19x1.56x2544.1x-29.53x-20.6x-.--% 20.45B
28.04x2.64x0.69x5.48x15.23x19x-.--% 18.65B
-444.22x14.75x8.53x34.97x4390.34x-421.28x-.--% 17.26B
22.63x2.45x-1.07x3.91x11.97x14.47x-.--% 16.71B
-503.17x20.63x10.63x36.35x-2284.69x-359.1x-.--% 14.9B
-110.84x19.05x1.76x7.77x-219.02x-85.01x-.--% 12.11B
15.01x3.87x1.51x4.12x9.76x11.01x-.--% 11.66B
15.79x8.06x0.04x9.53x15.89x15.6x-.--% 10.44B
34.54x5.64x-2.76x7.79x30.32x34.59x - 9.64B
-20.56x40.83x-0x21.56x-24.42x-19.96x-.--% 9.95B
-8.2x - -0.26x - -7.28x-7.06x-.--% 8.71B
-18.85x8.33x6.65x547.24x-16.15x-16.56x-.--% 8.42B
-31.4x - 0.98x - - - - 8.37B
-10.12x-17.91x18.99x85.19x-10.79x-10.43x-.--% 8.1B
Average -57.01x 17.67x 2.82x 208.97x 108.57x -51.57x 0.11% 17.25B
Weighted average by Cap. -49.54x 18.80x 2.24x 194.57x 120.54x -42.67x 0.25%
Bio Therapeutic Drugs